About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Sequent Scientific Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
512529
ISIN Demat
INE807F01027
Book Value
46.71
NSE Code
SEQUENT
Dividend Yield %
0.00
Market Cap
52120.21
P/E
386.36
EPS
0.53
Face Value
2
BSE
NSE
05-Dec-2025 09:43
BSE
NSE
NSE F & O
05-Dec-2025 09:34
BSE
NSE
NSE F & O
Last Price
204.40
Net Change
-3.25
% Change
-1.57%
Prev.Close
207.65
Open
207.70
High
207.70
Low
203.90
Volume
17396
Last Price
205.75
Net Change
-1.68
% Change
-0.81%
Prev.Close
207.43
Open
207.43
High
207.44
Low
204.30
Volume
209428
Value
3555742.4
Best Buy
204.25
Best Sell
204.50
Best Quantity
42
Sell Quantity
59
Today's Range
207.70
52-Week High
260.30
52-Week Low
111.00
Value
43089811
Best Buy
205.60
Best Sell
205.76
Best Quantity
16
Sell Quantity
5
Today's Range
207.44
52-Week High
257.85
52-Week Low
117.35
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
42
Price
204.25
Quantity
59
Price
204.50
Best Bid
Best Offer
Quantity
16
Price
205.60
Quantity
5
Price
205.76
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
23-Aug-19
29-Aug-19
Dividend
25 %
10-Sep-21
Company News
19-11-2025
Sequent Scientific inform...
17-11-2025
Sequent Scientific inform...
11-11-2025
Sequent Scientific inform...
11-08-2025
Sequent Scientific inform...
16-07-2025
Sequent Scientific inform...
14-07-2025
Sequent Scientific inform...
29-05-2025
SeQuent secures approvals...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.